Trading Signals: A Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Dec. 22, 2023)(Agilent Technologies Inc.)
| A latest price $127.9500 (-0.02%) ($127.8450 - $131.0800) on Tue. Feb. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.37% (three month average) | RSI | 57 | Latest Price | $127.9500(-0.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | A advances 0.7% a day on average for past five trading days. | Weekly Trend | A advances 2.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support A advance at 0% a week (0% probability) IVW(56%) VT(55%) VUG(55%) IWF(54%) SPY(53%) | Factors Impacting A price | A will decline at least -0.685% in a week (0% probabilities). VIXM(-36%) UUP(-24%) VXX(-11%) TBT(-8%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.685% (StdDev 1.37%) | Hourly BBV | 0.5 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $126.24(1.35%) | 10 Day Moving Average | $124.83(2.5%) | 20 Day Moving Average | $124.34(2.9%) | To recent high | -0.2% | To recent low | 20.8% | Market Cap | $39.537b | | | | Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment comprises activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA. |